1
/
의
1
AntibodySystem
SKU(재고 관리 코드):DHD14298
Cantuzumab ravtansine (ADC)
Cantuzumab ravtansine (ADC)
Catalog No.: DHD14298
| Catalog No. | DHD14298 |
|---|---|
| Product name | Cantuzumab ravtansine (ADC) |
| Size | 5 mg |
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Description | Cantuzumab ravtansine is an ADC consisting of a CanAg-directed antibody and DM4 that has extensive antitumor efficacy in a series of CanAg-positive human tumor xenografts. |
| Form | Liquid |
| Purity | >90% as determined by SEC. |
| Clonality | Monoclonal |
| Target | PEMT, CA 15-3, H23AG, Peanut-reactive urinary mucin, PEM, EMA, Cancer antigen 15-3, MUC-1, Episialin, MUC1-CT, MUC1-beta, Tumor-associated mucin, CD227, Polymorphic epithelial mucin, KL-6, MUC1-alpha, MUC1, PUM, Krebs von den Lungen-6, MUC1-NT, Tumor-associated epithelial membrane antigen, Mucin-1, Breast carcinoma-associated antigen DF3, Carcinoma-associated mucin |
| Purification | Purified by Ion Exchange Chromatography. |
| Endotoxin level | Please contact with the lab for this information. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternative Names | C242-DM4 |
| Clone ID | Cantuzumab ravtansine |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Share
